COVID-19 testing

As the world looks for ways to address the challenge of COVID-19, BD is here to help. The BD Veritor™ System for Rapid Detection of SARS-CoV-2, is used for patients suspected of having COVID-19 by their healthcare provider, and is a simple to administer point-of-care antigen test that delivers reliable results in 15 minutes.

Key benefits

Handheld portability | BD Veritor™ Plus System

Handheld portability

Simple Sample collection | BD Veritor™ Plus System

Simple sample collection

Fast, reliable results | BD Veritor™ Plus System

Fast, reliable results

Benefit Icon

Easy reporting options

Take testing to patients with
the BD Veritor™ Plus System

Content image

The BD Veritor™ Plus System streamlines the testing experience for CLIA-waived testing of SARS-CoV-2. Its handheld size and untethered portability allows you to take testing to patients.


    • BD Veritor™ Plus Analyzer
    • BD Veritor™ System SARS-CoV-2 Extraction Reagent
    • BD Veritor™ System SARS-CoV-2 Device
    • Sample collection swabs
    • BD Veritor™ System SARS-CoV-2 positive (+) and negative (-) control swabs

How it works

Dedicated to providing the help you need

“BD is a purpose-driven company, Advancing the World of Health™ by developing fundamental medical devices and sophisticated technologies that doctors, nurses, researchers and caregivers rely on to improve the lives of patients. As partners on the front lines, we’ve helped the world face down viral diseases for decades, from polio, smallpox and measles to HIV and the annual flu.

Today, the capabilities, expertise and global reach of BD are greater than ever, and in the face of COVID-19, we are mobilizing to equip our healthcare partners with a comprehensive suite of technologies and solutions that are essential to discovering more about the virus, diagnosing patients at scale and supporting patient care.

We’re doubling down on what we do best — tapping our deep resources to help solve healthcare’s biggest problems, working with urgency to innovate and ensure the front lines have what they need to address this crisis, and making an impact on lives around the world.“

Tom Polen, CEO and President

Working together to address the pandemic

Working together to address the pandemic


Expand access to COVID-19 diagnostic testing by collaborating with U.S. government agencies and molecular diagnostic companies, as well as validating alternate collection approaches.


Support patient management by facilitating complex care of critically ill patients and providing medical devices and training to expand access to care.


Help to facilitate the tracking and reporting of essential data to health agencies and providers, including insights on disease incidence, hospital utilization and capacity, and patient outcomes.

Get more information about BD and COVID-19:

Learn more

  1. BD Veritor™ System for Rapid Detection of SARS-CoV-2 Instructions for Use, package insert. Franklin Lakes, NJ: Becton, Dickinson and Company.